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Abstract
Background: The heart transplant is a treatment of the heart failure, which is not responding to medications, and its efficiency
is already proved: unfortunately, organ donation is a limiting step of this life-saving procedure.
To counteract heart donor shortage, we should screen aged potential donor hearts for initial cardiomyopathy and functionally
significant coronary artery disease.
Donors with a history of cardiac disease are generally excluded. Coronary angiography is recommended for most male donors
older than 45 years and female donors older than 50 years to evaluate coronary artery stenoses. A simpler way to screen aged
potential donor hearts for initial cardiomyopathy and functionally significant coronary artery disease should be stress
echocardiography.
Case report: A marginal donor (A 57 year old woman meeting legal requirements for brain death) underwent a
transesophageal (TE) Dipyridamole stress echo (6 minutes accelerated protocol) to rule out moderate or severe heart and
coronary artery disease. Wall motion was normal at baseline and at peak stress (WMSI = 1 at baseline and peak stress, without
signs of stress inducible ischemia). The pressure/volume ratio was 9.6 mmHg/ml/m2 at baseline, increasing to 14 mmHg/ml/m2
at peak stress, demonstrating absence of latent myocardial dysfunction.
The marginal donor heart was transplanted to a recipient "marginal" for co-morbidity ( a 63 year old man with multiple myeloma
and cardiac amyloidosis , chronic severe heart failure, NYHA class IV).
Postoperative treatment and early immunosuppressant regimen were performed according to standard protocols.
The transplanted heart was assessed normal for dimensions and ventricular function at transthoracic (TT) echocardiography on
post-transplant day 7.
Coronary artery disease was ruled out at coronary angiography one month after transplant; left ventriculography showed
normal global and segmental LV function of the transplanted heart.
Conclusion: For the first time stress echo was successfully used in the critical theater of screening potential donor hearts. This
method is enormously more feasible, less expensive, and more environmentally sustainable than any possible alternative strategy
based on stress scintigraphy perfusion imaging or coronary angiography. The selection of hearts "too good to die" on the basis
of bedside resting and stress echo can be a critical way to solve the mismatch between donor need and supply.
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Background
The heart transplant is a treatment of the heart failure,
which is not responding to medications, and its efficiency
is already proved: unfortunately, organ donation is a lim-
iting step of this life-saving procedure.
In fact, the selection of the organs that will be trans-
planted is based on two factors: a suitable donor, without
systemic diseases or neoplasia, active bacterial or viral
infections, or anyway according to Health Guidelines. For
the organ "heart", an additional criterion is represented by
the age; this factor is not so important in and by itself, but
for the associated age-dependent risk for asymptomatic
coronary artery disease or latent cardiomyopathy [1].
Generally, the age threshold is 55 years, older donors
being accepted in special cases, when the recipient's con-
dition is very poor and represents an emergency [2].
Heart donor shortage is a society problem. Patients in
heart transplant waiting list have a 7.3% death rate, and
the average waiting time is 2 to 3 years. In Italy, about 650
patients are in transplant list and only about 300 trans-
plant are performed each year, with a plateau in the last 5
years.
Furthermore, there is a large amount of marginal recipi-
ents, both for advanced age (> 65 years) or co-morbidity
in younger recipients [3,4].
To counteract heart donor shortage, we should screen
aged potential donor hearts for initial cardiomyopathy
and functionally significant coronary artery disease: a way
to select hearts "too good to die" on the basis of bedside
resting and stress echo can be a critical way to solve the
mismatch between donor need and supply. The Adonhers
(Aged Donor Heart Rescue by Stress Echo) Project was
approved by the Ethical Committee of the Sant'Orsola
Hospital of Bologna in January 2005 (Figure 1). The
project is now active in the Emilia-Romagna Region in its
pilot phase.
Case report
The marginal donor
A 57 year-old woman had a traffic accident with traumatic
brain death and was selected for organ donation. The
woman was older than the upper age limit of 55 for heart
donation.
Next, a careful cardiac history took form, with no back-
ground data of cardiac symptoms at rest or under effort.
There was a history of mild systemic hypertension. A 12 -
lead electrocardiogram resulted in non-specific T wave
changes, often seen in brain death.
Standard TT echocardiography
At time when doses of intravenous inotropic agents have
been lowered to as low as is compatible with adequate
blood pressure and cardiac output (noradrenaline 0.13 γ/
Kg/min + dobutamine 2.8 γ/Kg/min) and after adequate
fluid infusion a TT echocardiogram was taken demon-
strating normal global and segmental ventricular func-
tion, no valvular disease [5].
The pharmacological stress echo
To rule out moderate or severe heart and coronary disease,
a TE Dipyridamole stress echo (6 minutes accelerated pro-
tocol) was performed [6].
The echo images were tape-recorded and periodically dig-
itized. During the procedure, pressure and ECG were
recorded every minute [7]. Results of the transesophageal
dipyridamole stress echo are shown in Additional Files
(video clips) 1, 2,3, and 4. There was a normal response of
the left ventricle during stress. Brachial blood pressure was
measured with cuff sphygmomanometer. In every phase
of the stress echo, the projections of the 4 chambers and
of the apical 2 chambers were recorded to calculate the left
ventricular telesystolic volume. This allowed us to calcu-
late the systolic pressure/left ventricle telesystolic volume
ratio in every moment when increasing the cardiac fre-
quency during the stress and building, off-line, the force-
frequency relation (FFR) of the left ventricle [8].
The results of the stress
Wall motion was normal at baseline and at peak stress
(WMSI = 1 at baseline and peak stress), without signs of
stress inducible ischemia (Additional files 1, 2, 3, and 4).
The pressure/volume relation was 9.6 mmHg/ml/m2 at
baseline, increasing to 14 mmHg/ml/m2 at peak stress,
FFR slope = 28 mmHg/ml/m2  /bpm demonstrating
absence of latent myocardial dysfunction (Figure 2).
Systemic blood pressure decreased from 120/60 mmHg at
baseline to 100/45 mmHg at peak stress.
LVEF % increased from 63% at baseline to 77% at peak
stress.
Based on the dipyridamole stress results, despite the age
beyond the 55 years limit, the heart was chosen for ortho-
topic heart transplantation, and was explanted with stand-
ard technique.
The marginal recipient
The recipient was "marginal" for co-morbidity. He was a
63 year old man with multiple myeloma and cardiac amy-
loidosis, chronic severe heart failure, NYHA class IV, LVEF
= 13% (TT echocardiography, Figure 3) [9].Cardiovascular Ultrasound 2006, 4:3 http://www.cardiovascularultrasound.com/content/4/1/3
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The echo-driven destiny of candidate donor heart Figure 1
The echo-driven destiny of candidate donor heart. To screen aged potential donor hearts for initial cardiomyopathy and func-
tionally significant coronary artery disease, potential donors aged > 55 years will undergo pharmacological stress echo (with 
either dipyridamole or dobutamine). Hearts with normal regional and global left ventricular function will be recruited. Hearts 
with stress echo positivity will be excluded. Excluded hearts will undergo cardioautoptic verification to challenge stress echo 
results versus a pathologic gold standard. Included hearts will be transplanted and the stress echo result will be challenged ver-
sus clinical outcome and angiographic verification 1 month after transplant. The Adonhers (Aged Donor Heart Rescue by 
Stress Echo) Project Additional files (video clips) 1, 2, 3, and 4. A transesophageal pharmacological stress echo test was per-
formed, following the protocol of American Society of Echocardiography [5], using: Dipyridamole (0.84 mg/kg in 6'). The 
echocardiographic study is divided into two different parts: 1 Segmental wall motion- it is the essential step for the evaluation. 
The donor with abnormal wall motion at baseline or during stress will be excluded from the donor ship. The donor showed 
normal regional wall motion at baseline and during stress. (WMSI = 1 at baseline, intermediate and peak stress). Global and 
regional wall motion is shown in 2 and 4 chambers view at baseline (Additional files 1 and 2) and at peak stress (Additional files 
3 and 4). 2 The force-frequency relation (FFR). During the procedure, pressure and ECG were recorded every minute. Bra-
chial blood pressure was measured with cuff sphygmomanometer. In every phase of the stress echo, the projections of the 4 
chamber and of the apical 2 chambers were recorded to calculate the left ventricular telesystolic volume. This allowed us to 
calculate the systolic pressure/left ventricle telesystolic volume ratio in every moment when increasing the cardiac frequency 
during the stress and building, off-line, the force-frequency relation of the left ventricle. The donor had normal response at rest 
and with normal regional wall motion during pharmacological stress echo and was considered suitable donor; indeed, this 
response pattern proved a good coronary and functional reserve of the heart. (Images from Sonia Gherardi, Director Echo lab, 
Cardiology Division, Cesena Hospital, Italy)Cardiovascular Ultrasound 2006, 4:3 http://www.cardiovascularultrasound.com/content/4/1/3
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The heart transplant
The operation was performed by way of a median sternot-
omy incision, with cannulation of the aorta and both
venae cavae. The implantation procedure required one
hour. The incision was closed after placement of tempo-
rary pacing wires and chest drainage catheters [10].
The transplant outcome
After the transplant, the patient underwent a routine treat-
ment and follow-up procedure.
Standard postoperative treatment was performed, mobili-
zation and physical therapy was begun the day 7 after sur-
gery.
Early immunosuppressant regimen was started according
to the standard protocols.
The echo control
The transplanted heart was assessed normal for dimen-
sions and ventricular function at TT echocardiography on
post-transplant day 7 (Additional files 5 and 6).
The transplanted heart coronary angiography
Coronary artery disease of the transplanted heart was
ruled out at coronary angiography one month after trans-
plant; left ventriculography showed normal global and
segmental LV function (Figure 4).
Discussion
Supply of donor hearts is a critical rate-limiting step in
heart transplantation. An effective way to solve the current
shortage would be to accept an upward shift of the age cut-
off limit (from current 45 to 70 years) but age-related high
prevalence of asymptomatic coronary artery disease and
occult cardiomyopathy severely limit the feasibility of this
approach.
Pharmacological stress echo is inexpensive, non-invasive
and allows a simultaneous evaluation of inducible
ischemia and contractile reserve of the left ventricle –
therefore, it is capable to unmask prognostically meaning-
ful occult coronary artery disease or cardiomyopathy
[6,7].
The excellent prognosis associated with a negative stress
echo test is already well documented by databases of
thousands of patients with known or suspected coronary
artery disease [11].
Force-Frequency relationship (FFR) is a theoretically and
methodologically robust method for the assessment of
left ventricular contractility and can be assessed non-inva-
sively during exercise echo. [8] Previous studies demon-
strated that an up sloping FFR better identifies hearts
without latent left ventricular dysfunction than standard
5% of cutoff stress increase in LVEF [12].
This first described case regards stress in special conditions
– such as those occurring in a candidate donor. Drug infu-
sion may create special problems of hemodynamic insta-
bility (and, therefore, of stress tolerance) and
The force-frequency curve with DIP stress echo in the  Donor heart Figure 2
The force-frequency curve with DIP stress echo in the 
Donor heart. Upper panel: An increased heart rate is accom-
panied by smaller end-systolic volumes (normal up sloping 
FFR). The pressure/volume relation was 9.6 mmHg/ml/m2 at 
baseline, increasing to 14 mmHg/ml/m2 at peak stress, FFR 
slope = 28 mmHg/ml/m2/bpm demonstrating absence of 
latent myocardial dysfunction. Middle and lower panels. Sys-
temic blood pressure and LVEF % at baseline and peak stress. 
A stress induced increase in LVEF simultaneously to stress 
induced systolic and diastolic pressure decrease is confound-
ing for the contractile reserve evaluation.Cardiovascular Ultrasound 2006, 4:3 http://www.cardiovascularultrasound.com/content/4/1/3
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echocardiographic feasibility and interpretation of the
results.
For this reason, we considered ethically sound to use the
organ considered suitable using this method, for trans-
plant in recipients in emergency or suboptimal condi-
tions. It is already a current policy to transplant suitable
organs removed from donors aged more than 55 years, to
patients with relative contraindications to transplant. In
this context, a stress echo test will be a further reason of
warranty for the recipient, while a change in policy based
on stress echo results would only be unwarranted at this
stage of evidence. It is obvious that the ultimate target may
be the removal of the "age factor" and its replacement
with a stress echo driven selection, but this far-reaching
change in selection policy has to go through several inter-
mediate check points.
Conclusion
The relevance of this case is:
Scientific: for the first time, a largely validated technology
such as stress echo is used in the critical theater of screen-
ing potential donor hearts.
Clinical: the efficacy of an echo-driven strategy for select-
ing donor heart is enormously more feasible, less expen-
sive, and more logistically sustainable than any possible
alternative strategy based on stress scintigraphy perfusion
imaging or coronary angiography, which cost respectively
3 times and 10 times more than a stress echo and are
much more logistically demanding.
Social: heart donor shortage is a society problem. Patients
in heart transplant waiting list have a 7.3% death rate, and
the average waiting time is 2 to 3 years. In Italy, about 650
patients are in transplant list and only about 300 trans-
plants are performed each year, with a plateau in the last
5 years. A better way to select hearts "too good to die" on
the basis of bedside resting and stress echo can be a critical
way to solve the mismatch between donor need and sup-
ply.
Economic: the cost of a donor heart is estimated around
200.000  € in the "transplant black market". We can
recruit otherwise ineligible donor at the cost of 1 stress
echo, with enormous obvious downstream economic
benefits.
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Graft coronary artery imaging- appearance by angiography  and intravascular ultrasound 1 month after follow-up Figure 4
Graft coronary artery imaging- appearance by angiography 
and intravascular ultrasound 1 month after follow-up. Excel-
lent angiographic result demonstrating concordance with the 
pre-transplant potential donor stress echo (no inducible 
ischemia). The left panel shows angiogram obtained on the 
transplanted heart 1 month after engraftment. Angiographic 
imaging of the midportion of the LAD only shows minor 
lumen irregularities within the vessel. The right panel shows 
intravascular ultrasound images obtained in the same coro-
nary segment. (images from Prof Claudio Rapezzi and Dr 
Carlo Magelli, responsible of the Clinical Heart Transplant 
Program, University Cardiology Division, S. Orsola Hospital, 
Bologna, Italy)
Two-dimensional transthoracic echocardiogram recorded in  the marginal recipient with cardiac amyloid Figure 3
Two-dimensional transthoracic echocardiogram recorded in 
the marginal recipient with cardiac amyloid. In both the par-
asternal long-axis (right) and apical four-chamber (left) 
images note the homogeneous echo intensity of the myocar-
dium, which is noted as a bright "speckling" appearance. Both 
the mitral and aortic valves are also thickened. The patient 
had severe ventricular dysfunction and advanced heart failure 
symptoms (NYHA Class IV). (Images from Marinella Ferlito, 
Director Echo lab, and Prof Claudio Rapezzi, University Car-
diology Division, S. Orsola Hospital, Bologna, Italy) Addi-
tional files (video clips) 5 and 6. Two-dimensional 
transthoracic echocardiogram of the donor heart grafted in 
the marginal recipient. In both the parasternal long-axis 
(Additional file 5) and apical four-chamber (Additional file 6) 
views note the excellent global and regional ventricular func-
tion. Chambers and cardiac structures are normals. (Images 
from Marinella Ferlito, Director Echo lab, and Prof Claudio 
Rapezzi, University Cardiology Division, S. Orsola Hospital, 
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